137 related articles for article (PubMed ID: 10515369)
1. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?
Shirwan H
Transplantation; 1999 Sep; 68(6):715-26. PubMed ID: 10515369
[TBL] [Abstract][Full Text] [Related]
2. Predominant expression of the Th2 response in chronic cardiac allograft rejection.
Mhoyan A; Wu GD; Kakoulidis TP; Que X; Yolcu ES; Cramer DV; Shirwan H
Transpl Int; 2003 Aug; 16(8):464-73. PubMed ID: 12712237
[TBL] [Abstract][Full Text] [Related]
3. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response.
Csencsits K; Wood SC; Lu G; Magee JC; Eichwald EJ; Chang CH; Bishop DK
Eur J Immunol; 2005 Mar; 35(3):843-51. PubMed ID: 15714582
[TBL] [Abstract][Full Text] [Related]
4. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
Barbara JA; Turvey SE; Kingsley CI; Spriewald BM; Hara M; Witzke O; Morris PJ; Wood KJ
Transplantation; 2000 Dec; 70(11):1641-9. PubMed ID: 11152227
[TBL] [Abstract][Full Text] [Related]
5. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
[TBL] [Abstract][Full Text] [Related]
6. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
7. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
Fowler DH; Gress RE
Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
[TBL] [Abstract][Full Text] [Related]
8. Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection.
VanBuskirk AM; Wakely ME; Orosz CG
Transplantation; 1996 Jul; 62(2):229-38. PubMed ID: 8755821
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
Clement JD; Chan SY; Bishop DK
Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
[TBL] [Abstract][Full Text] [Related]
10. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
Qin L; Ding Y; Tahara H; Bromberg JS
J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
[TBL] [Abstract][Full Text] [Related]
11. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption.
Demetris AJ; Murase N; Ye Q; Galvao FH; Richert C; Saad R; Pham S; Duquesnoy RJ; Zeevi A; Fung JJ; Starzl TE
Am J Pathol; 1997 Feb; 150(2):563-78. PubMed ID: 9033271
[TBL] [Abstract][Full Text] [Related]
12. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens.
Coudert JD; Coureau C; Guéry JC
J Immunol; 2002 Sep; 169(6):2979-87. PubMed ID: 12218112
[TBL] [Abstract][Full Text] [Related]
13. Role of indirect allorecognition in allograft rejection.
Sayegh MH; Carpenter CB
Int Rev Immunol; 1996; 13(3):221-9. PubMed ID: 8782743
[TBL] [Abstract][Full Text] [Related]
14. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
[TBL] [Abstract][Full Text] [Related]
15. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
[TBL] [Abstract][Full Text] [Related]
16. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
17. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection.
Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229
[TBL] [Abstract][Full Text] [Related]
18. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T
Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637
[TBL] [Abstract][Full Text] [Related]
19. Cytokines affecting CD4
Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
